Yervoy, also known as ipilimumab, is a prescription medication used to treat certain types of skin cancer, including melanoma. The Yervoy discount program, managed by Bristol Myers Squibb, the manufacturer of the drug, offers financial assistance to eligible patients.

According to the Bristol Myers Squibb website, the Yervoy Patient Assistance Program is available to patients who meet specific income guidelines and have no prescription insurance coverage or inadequate coverage [1]. The program provides discounted Yervoy medication to eligible patients for an extended period.

However, the specific duration of the Yervoy discount program is not clearly stated on the manufacturer's website. It is recommended that patients contact the Bristol Myers Squibb patient assistance program directly for more information on eligibility and program duration [2].

For more details on the Yervoy discount program and other financial assistance options, patients can visit the Bristol Myers Squibb website or contact their healthcare provider. They can also refer to DrugPatentWatch.com [3] for information on the patent status and availability of Yervoy.

Sources:

[1] Bristol Myers Squibb. (n.d.). Yervoy Patient Assistance Program. Retrieved from https://www.bms.com/our-company/patient-assistance/yervoy-patient-assistance-program.html.

[2] Bristol Myers Squibb. (n.d.). Contact Us. Retrieved from https://www.bms.com/about-bms/contact-us.html.

[3] DrugPatentWatch.com. (n.d.). Yervoy. Retrieved from https://www.drugpatentwatch.com/drug/Yervoy/ipilimumab.